RecruitingNCT07197957
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
Clinical Utility of Cystatin C in the Early Detection of Contrast Induced Acute Kidney Injury
Sponsor
BayCare Health System
Enrollment
100 participants
Start Date
Mar 11, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Subjects ages 18 years and above
- Inpatients with CKD (Figure 1)
- Order for CT imaging study or coronary angiography with isohexol Omnipaque) contrast media.
- Pre and post contrast available
- All races and ethnicity of patients are eligible. We expect to analyze approximately equal number of men and women in this study.
Exclusion Criteria8
- Preexisting dialysis
- Patients under the age of 18 years
- Pregnancy
- Incarcerated individuals
- Patients with impaired cognition and unable to follow consent procedures
- Recent exposure to CM (within 2 days before/after procedure)
- Cardiac shock
- Medications that affect biomarkers, including corticosteroids, lfamethoxazoletrimethoprim
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07197957
Related Trials
Improving Patient Assessment After Acute Kidney Injury (AKI)
NCT075695881 location
LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
NCT058794329 locations
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
NCT0721570271 locations
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
NCT059091501 location
Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels
NCT053492921 location